GHK-Cu and hair thickness: what the evidence actually says

What did @rachaelsignorelli actually say?

She used GHK-Cu peptide for nine weeks on a five-days-on, two-days-off schedule and reported that "the deeper breakouts have stopped" but that her skin hasn't fully cleared. She also says her skincare products were "breaking down my barrier" before she switched to gentler options, and she credits the product change as much as the peptide for her improvement.

This is a notably honest self-report. She doesn't claim a cure. She acknowledges ongoing "little pustules" and picks at them, which she admits. She frames her experience with appropriate uncertainty: "Everyone's skin is different. So for me, it's helped, but it hasn't entirely cleared up my skin." That kind of measured language is rare in peptide content, and it deserves credit.

She's describing what sounds like adult-onset hormonal acne, concentrated on the chin and jawline, which is a clinically recognizable pattern associated with androgen fluctuations. Whether GHK-Cu addressed that, or whether fixing a disrupted skin barrier did most of the work, is the real question worth examining.

Does the science back this up?

The honest answer is: partially, and with significant caveats. GHK-Cu has legitimate research behind it for wound healing and skin remodeling, but the evidence specific to inflammatory acne is thin and mostly preclinical.

GHK-Cu (copper tripeptide-1) has demonstrated anti-inflammatory properties in multiple in vitro studies. Pickart and Margolina (2018, Cosmetics) reviewed decades of GHK-Cu research and documented its ability to suppress pro-inflammatory cytokines including TNF-alpha and IL-6, which are active in acne pathogenesis. Separately, research by Gorouhi and Maibach (2009, International Journal of Cosmetic Science) confirmed its role in stimulating collagen synthesis and skin barrier repair, which could plausibly explain why someone with a severely compromised barrier might see improvement.

Here's the problem: none of this research was conducted on hormonal acne specifically. Most GHK-Cu acne-related claims are extrapolated from wound healing and anti-inflammatory data. There are no published randomized controlled trials on GHK-Cu as a treatment for hormonal or cystic acne. What she experienced over nine weeks could reflect GHK-Cu activity, the switch to non-barrier-disrupting cleansers, or the natural cycling of hormonal acne, which often fluctuates on its own.

What did they get wrong (or right)?

She got the barrier piece right, and that's actually the more evidence-supported part of her story. Her old products were likely over-exfoliating or using actives that worsened inflammation. Switching to La Roche-Posay's hydrating cleanser and a basic moisturizer is consistent with dermatological guidance for compromised skin barriers. Studies like Elias (2008, Journal of Investigative Dermatology) have established that a disrupted stratum corneum drives inflammation that worsens acne independently of Cutibacterium acnes presence.

What she got murkier is the attribution. She credits the peptide for stopping deep cystic breakouts but doesn't account for the simultaneous skincare overhaul. That's a confounding variable she acknowledges but doesn't fully reckon with. It's possible the peptide contributed. It's equally possible that stopping harsh actives did most of the heavy lifting.

One thing worth flagging: she mentions getting product recommendations from "Chachi Beauty," which appears to be an AI chatbot-assisted skincare service. That's not medical advice, and for someone dealing with hormonal acne severe enough to require pimple-strip patches across her entire chin, a dermatologist consultation would be a more appropriate starting point than an AI skincare concierge.

What should you actually know?

GHK-Cu has real science behind it for skin applications, more so than most peptides currently trending on TikTok. But the evidence base is almost entirely in vitro or observational, and the specific claim that it treats hormonal acne is not supported by clinical trials. Hormonal acne driven by androgen fluctuations typically requires interventions that address the hormonal root cause: oral contraceptives, spironolactone, or in some cases isotretinoin, all of which have robust evidence behind them.

If you're 29 and suddenly developing cystic jawline acne that was never a problem before, the right first move is bloodwork and a conversation with a dermatologist or OB-GYN, not peptides. That said, GHK-Cu applied topically or used as she describes is generally considered low-risk, and its anti-inflammatory and barrier-supportive properties mean it's unlikely to make things worse. "Helped but hasn't entirely cleared" is a realistic description of what the evidence would predict.

The skincare product change she made is, frankly, probably the most evidence-supported intervention she describes. Gentle cleansers and basic moisturizers for a compromised barrier have stronger clinical backing than GHK-Cu for acne specifically.